Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

NCT00700713 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis
Meningococcemia

Interventions

BIOLOGICAL: Meningococcal polysaccharide diphtheria toxoid conjugate
BIOLOGICAL: Meningococcal polysaccharide diphtheria toxoid conjugate
BIOLOGICAL: Meningococcal polysaccharide diphtheria toxoid conjugate

Sponsor

Sanofi Pasteur, a Sanofi Company